Emla Patch 2.5 % (Prilocaine PATCH) 2.5 %

EMLA Patch 2.5% is a topical anesthetic patch containing prilocaine for numbing the skin. It is commonly used for pain relief during minor medical procedures. This product is manufactured by Aspen Pharmacare Canada Inc.

Strength

2.5 %

Pack Size

2/20

Manufacturer / TM Owner

ASPEN PHARMACARE CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EMLA Patch 2.5% is primarily used for topical anesthesia. It is often applied to the skin to provide numbing effects before procedures like needle insertions or minor surgeries. This patch is designed to help reduce pain and discomfort associated with these procedures. People often ask, 'What is EMLA Patch used for?' and the answer is typically for localized pain relief and anesthesia.

Side Effects

When applied to the skin, EMLA Patch 2.5% works by numbing the area, which can help reduce pain and discomfort. The effects are usually felt within about an hour of application and can last for several hours. Some users may experience temporary skin redness or itching at the application site.

Precautions & Warnings

EMLA Patch 2.5% should be used as directed and only on intact skin. Avoid applying it to broken or irritated skin. It is important to follow the instructions provided with the product to ensure safe and effective use. Always consult a healthcare professional if you have any concerns about using this patch.

Avoid Interactions

EMLA Patch 2.5% may interact with other topical medications or treatments applied to the same area. It is generally advised to avoid using this patch with other products unless directed by a healthcare professional. Additionally, some individuals may be sensitive to the ingredients in the patch, so it is important to monitor for any adverse reactions.

Frequently Asked Questions

EMLA Patch 2.5% is used for topical anesthesia, typically to numb the skin before minor medical procedures.

The numbing effects of EMLA Patch 2.5% usually start within about an hour of application.

No, EMLA Patch 2.5% should not be applied to broken or irritated skin.

Common side effects may include temporary skin redness or itching at the application site.

It is generally advised to avoid using EMLA Patch 2.5% with other topical medications unless directed by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.